SEO URLwww.firestrike.ai/deals/organon-sun-pharma-acquisition-2026
acquisitionAnnounced · Apr 27, 2026PharmaceuticalsSource · CredibleArticle · Factual
Sun Pharma acquires Organon
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$11.75B
Target
Organon
NYSE: OGN · Jersey City, New Jersey
Acquirer
Sun Pharma
Full Acquisition
Status
Pending
Sun Pharma agreed to acquire Organon. Reported deal value: $11.75B. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Jersey City, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-04-27. Figures and status may change as filings and press coverage update.
Medium Large AHMEDABAD: Homegrown pharma major Sun Pharmaceutical Industries Ltd on Monday announced it has signed a definitive agreement to acquire US-based Organon & Co in an all-cash transaction at $11.75 billion
Deal timeline
Announced
Apr 27, 2026 · timesofindia.indiatimes.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $11.75B. Figures and status may change as sources update.
Sources: timesofindia.indiatimes.com · Primary article · FireStrike proprietary index